These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 10598827)
1. Increased urinary phosphate excretion in pseudohypoparathyroidism type II with long-term treatment with phosphodiesterase inhibitor. Mano T; Uchimura K; Hayashi R; Kobahashi T; Fujiwara K; Makino M; Kakizawa H; Nagata M; Nakai A; Wada M; Nagasaka A; Itoh M Horm Metab Res; 1999 Nov; 31(11):602-5. PubMed ID: 10598827 [TBL] [Abstract][Full Text] [Related]
2. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)]. Yamada K; Tamura Y; Yamamoto M; Kumagai A Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053 [TBL] [Abstract][Full Text] [Related]
3. Separation of pseudohypoparathyroidism into types I and II using only basal nephrogenous cAMP determinations. Singhellakis P; Pappas A; Nicolou CH; Ikkos D Endocrinologie; 1991; 29(1-2):67-71. PubMed ID: 1666440 [TBL] [Abstract][Full Text] [Related]
4. Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations. Kutílek S; Kabícek P; Nedvídková J; Bayer M Turk J Pediatr; 2001; 43(1):70-5. PubMed ID: 11297164 [TBL] [Abstract][Full Text] [Related]
5. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia]. Iida S Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786 [TBL] [Abstract][Full Text] [Related]
6. Pseudohypoparathyroidism showing positive phosphaturic and negative cyclic AMP excretion response to parathyroid hormone. Higashi K; Honda K; Morita M; Umeda T; Shimada T; Kimura K; Shido T; Arita I; Sato T Endocrinol Jpn; 1989 Aug; 36(4):465-9. PubMed ID: 2555146 [TBL] [Abstract][Full Text] [Related]
7. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism. Yamada K; Tamura Y; Yamamoto M; Kumagai A Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161 [TBL] [Abstract][Full Text] [Related]
8. [Urinary excretion of cAMP after PTH injection in patients with hypohyperparathyroidism (author's transl)]. González Macías J; Gertner JM; Brenton DB Med Clin (Barc); 1979 Oct; 73(6):219-21. PubMed ID: 232737 [TBL] [Abstract][Full Text] [Related]
9. [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]. Bando Y; Miyakoshi H; Nagaoka T; Ohsawa K; Kobayashi K Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):676-87. PubMed ID: 1516722 [TBL] [Abstract][Full Text] [Related]
10. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)]. Stögmann W Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830 [TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP. Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459 [TBL] [Abstract][Full Text] [Related]
12. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects]. Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236 [TBL] [Abstract][Full Text] [Related]
13. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)]. Stögmann W Padiatr Padol Suppl; 1977; (5):63-9. PubMed ID: 199875 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster. Knox FG; Preiss J; Kim JK; Dousa TP J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974 [TBL] [Abstract][Full Text] [Related]
15. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine]. Gennari C; Galli M; Montagnani M; D'Amore I Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633 [TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone infusion test in children and adolescents. Hochberg Z; Moses AM; Richman RA Miner Electrolyte Metab; 1984; 10(2):113-6. PubMed ID: 6321936 [TBL] [Abstract][Full Text] [Related]
17. Effects of theophylline on urinary excretion of cyclic AMP, calcium, and phosphorus in normal subjects. Colin AA; Kraiem Z; Kahana L; Hochberg Z Miner Electrolyte Metab; 1984; 10(6):359-61. PubMed ID: 6095002 [TBL] [Abstract][Full Text] [Related]
18. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I. Mizunashi K; Furukawa Y; Abe K; Yoshinaga K Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049 [TBL] [Abstract][Full Text] [Related]
19. Stimulation by interleukin-1 of renal calcium reabsorption in thyroparathyroidectomized rats. Caverzasio J; Rizzoli R; Vallotton MB; Dayer JM; Bonjour JP J Bone Miner Res; 1993 Oct; 8(10):1219-25. PubMed ID: 8256659 [TBL] [Abstract][Full Text] [Related]
20. [Suspected case of pseudohypoparathyroidism type II]. Kitai Y; Yamamoto T; Iwaki M; Ohata Y; Mizoguchi Y; Sumi K; Fujikawa Y; Shimotsuji T Clin Calcium; 2005 Sep; 15 Suppl 1():80-2. PubMed ID: 16272636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]